clobazam for LGS
Selected indexed studies
- Refining management strategies for Lennox-Gastaut syndrome: Updated algorithms and practical approaches. (Epilepsia Open, 2025) [PMID:39700524]
- Lennox-Gastaut syndrome: a comprehensive review. (Neurol Sci, 2018) [PMID:29124439]
- Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. (Exp Neurol, 2023) [PMID:36206805]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. (2023) pubmed
- Clobazam. (2007) pubmed
- Refining management strategies for Lennox-Gastaut syndrome: Updated algorithms and practical approaches. (2025) pubmed
- Lennox-Gastaut syndrome: a comprehensive review. (2018) pubmed
- Antiseizure medications for Lennox-Gastaut Syndrome: Comprehensive review and proposed consensus treatment algorithm. (2025) pubmed
- Clobazam Therapy and CYP2C19 Genotype. (2012) pubmed
- Epileptic encephalopathy. (2001) pubmed
- Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome. (2013) pubmed
- Clobazam for patients with Lennox-Gastaut syndrome and epilepsy. (2012) pubmed
- An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome. (2019) pubmed